Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 406 (OTC: $CSUI) (TSXV: $SUGR.V) (OTC: $RLLRF) (TSXV: $EMH.V) (OTCQX: $EMHTF)
Delta, Kelowna, BC, April 29, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today’s podcast will be looking at a few public company announcements as well as state and city regulatory changes in the works.
To differentiate itself from other Cannabis based companies, Cannabis Suisse Corp (OTC: CSUI) announced creating some new cannabis products, their Alpine Cannabis Hemp Extract Oils..
CBD-related products have been increasingly popular over the recent few years. And it's been happening for a reason. CBD doesn't get users high and has an ability to treat multiple conditions and diseases. Apart from that, the U.S. DEA has officially removed the CBD with little to no THC from their list of controlled substances.
Cannabis Suisse’s high-grade cannabis oil will be sold in concentrations of 10%, 15%, and 25% CBD. It is produced in Switzerland and supplied to both medical and recreational vendors. However, there are some market and legal restrictions that may apply outside of Switzerland.
Cannabidiol, also known as CBD, oil can be obtained from Cannabis plants along with over 100 other compounds. It is widely used in therapeutics and is known to ease the symptoms of anxiety, epilepsy and even cancer.
As of now, the most significant research confirms positive effects of CBD oil for patients experiencing seizures (https://www.nature.com/articles/s41598-019-44056-y). Scientists tend to believe that CBD oil helps repress seizures by slowing down signals that are sent to the brain and by changing levels of calcium in brain cells thus decreasing inflammation in the brain. Some studies suggest that CBD may help with diabetes, heart diseases, substance abuse, mental disorders and certain types of cancers. CBD can have a beneficial effect on the skin due to anti-inflammatory properties and the ability to control skin pores and glands.
Sugarbud Craft Growers Corp. (TSXV: SUGR) (OTC: RLLRF) announced that as part of the previously announced third-party licensing and distribution agreement with Agro-Greens Natural Products Ltd. it will officially launch its Craft Cannabis Collection of adult use recreational cannabis products on June 23, 2020.
Sugarbud also announced that it has filed and been receipted for a preliminary short-form prospectus with the securities regulatory authorities in all provinces of Canada (except Québec) in connection with a commercially reasonable "best efforts" marketed public offering of secured convertible debenture units at a price of $1,000 per Debenture Unit for gross proceeds of up to a maximum of $4.0 million. Mackie Research Capital Corporation will act as sole book-runner and agent in respect of the Offering.
"Comprised of some of the most exquisite and exclusive strains, the Sugarbud Craft Cannabis Collection promises to deliver an exceptional experience to even the most discerning of customers," stated Sugarbud CEO, John Kondrosky. "In addition to the consistency of our flower, we view potency and terpene profiles to be a very strong indicator of quality and, based upon our results to date, we could not be more thrilled with what we have currently in our new product pipeline," continued Mr. Kondrosky. "Our operating and cultivation teams continue to execute extremely well and in a manner consistent with our vision to deliver superior products to legal markets in Canada. With an average total THC value of 23.6%1 across our entire first harvest, we view the results we have achieved to date as a clear indication of superior outcomes and we have every reason to believe that our approach to the cultivation of ultra-premium craft cannabis will consistently deliver on our commitment to quality and an exceptional consumer experience," continued Mr. Kondrosky.
"The launch of the Sugarbud Craft Cannabis Collection and our entry into the recreational cannabis market in Canada represents both a pivotal and transformational catalyst for growth and value creation for Sugarbud," concluded Mr. Kondrosky.
Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) announced its new nanoemulsion-based Fast Action Spray product line, an important step in Emerald’s Cannabis 2.0 strategy and a unique offering in the Canadian cannabis marketplace. This unique formulation offers notable advantages over existing formats of cannabis consumption in terms of convenience and predictability of consumption. The product line will consist of CBD and THC cannabinoids mixed with specific terpenes and flavorings. The first product is planned for launch in June.
Emerald’s first product is a CBD 12.5 mg/mL + myrcene combination that it expects to launch for medical users in June. Additional products include a CBD 15 mg/mL lemon + limonene combination and a THC 15 mg/mL citrus + limonene combination, expected to be launched in July into adult-use channels. Emerald has chosen to add specific all-natural terpenes to its nanoemulsion product line: myrcene has been shown to have anti-inflammatory, analgesic, and anxiolytic properties; limonene has been shown to have anti-inflammatory, analgesic, antioxidant, antidepressant and immunostimulating attributes*. Emerald is also developing “flavour-masked” versions, which will have significantly less cannabis flavour. All of the Fast Action Spray products will be packaged in 15 mL bottles.
“This is a game-changing new product category for the Canadian cannabis marketplace,” said Riaz Bandali, President & CEO of Emerald. “Our nanoemulsion product line offers convenience, predictability, no odour, and attractive value relative to the amount of absorbable active ingredient. We believe these products offer both medical and adult-use consumers a tremendously advantageous choice compared to inhaled or edible products to achieve desired outcomes from cannabis. We are pleased with the interest from cannabis distribution boards in multiple provinces that we have experienced about this new product and look forward to soon launching this line.”
Lastly we look at regulations, the section of the industry that is facing a lot of change and pushback as this pandemic continues.
In recent news in Denver, a new working group whose membership comprises of marijuana industry and community stakeholders aims to have the City of Denver's ear on pot licensing issues such as weed delivery and hospitality businesses.
In an April 27 memo sent to marijuana business owners in Denver, the Denver Department of Excise and Licenses described the Marijuana Licensing Work Group, a 24-person advisory board that will "review, discuss and make recommendations on policy direction and possible marijuana licensing laws, rules and regulation," according to the announcement.
The MLWG will review licensing opportunities granted by two new laws allowing pot delivery and social consumption businesses in Colorado. Both laws require local approval before such services are allowed within a municipality's borders, and the working group has been a planned step in Denver's exploration of the new opportunities.
Virtual meetings are currently scheduled to take place May 14, May 28, June 11 and June 25 on Zoom to avoid human interaction during the COVID-19 pandemic; those online meetings are open to the public.
This is not the only regulatory change in the works and I would recommend Cannabis Business Times for more updated news regarding state by state regulation changes during the COVID-19 Pandemic.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Disclosure: CSUI is a paid monthly news and social media cannabis company on Investorideas.com Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Contact Investorideas.com
800 665 0411
